Virtus ETF Advisers’s Adicet Bio ACET Stock Holding History

Virtus ETF Advisers’s Portfolio ACET Stock Details ACET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-594	Closed	-$54.8K	–	436
2023 Q1	$54.8K	Sell	594 -229	-28%	-$28.7K	0.03%	428
2022 Q4	$118K	Buy	823 +245	+42%	+$61.1K	0.06%	424
2022 Q3	$132K	Buy	578 +4	+0.7%	+$1.01K	0.05%	374
2022 Q2	$134K	Sell	574 -105	-15%	-$23.1K	0.05%	340
2022 Q1	$217K	Sell	679 -40	-6%	-$9.2K	0.1%	193
2021 Q4	$201K	Buy	+719	New	+$123K	0.08%	206
2018 Q4	–	Sell	-379	Closed	-$642K	–	308
2018 Q3	$642K	Sell	379 -278	-42%	-$363K	0.07%	86
2018 Q2	$673K	Buy	+657	New	+$707K	0.6%	112

Other funds holding ACET

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Virtus ETF Advisers's ACET Position: Q2 2023 in Review

Virtus ETF Advisers sold out of Adicet Bio (ACET) in Q2 2023, closing a stake of 594 shares — an estimated $54.8K sold.

Virtus ETF Advisers first reported a position in ACET in Q2 2018 and held it in 8 quarters. The position peaked at $673K in Q2 2018. 94 funds tracked by Wall St. Rank hold ACET as of Q2 2023.

Virtus ETF Advisers reported no remaining Adicet Bio position as of Q2 2023 after selling out during the quarter.
Virtus ETF Advisers sold 594 Adicet Bio shares in Q2 2023, an estimated $54.8K.
Virtus ETF Advisers first reported a position in Adicet Bio in Q2 2018 and held it in 8 quarters.
Virtus ETF Advisers's Adicet Bio position peaked at $673K in Q2 2018.
94 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2023.

Based on Virtus ETF Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.